News
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...
Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic ...
With the duration and frequency of cough episodes increasing among Indians since the onset of COVID-19, Kenvue, the world’s ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
3don MSN
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director Kirk Perry on an interim basis, and the confirmation that Kenvue is ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results